Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-003337
Filing Date
2019-02-28
Accepted
2019-02-28 16:57:09
Documents
1
Period of Report
2019-02-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3916
  Complete submission text file 0001213900-19-003337.txt   5420
Mailing Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019
Business Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019 646-844-1164
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address
Kidron Miriam (Reporting) CIK: 0001409232 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 19644418